
BioBeats evolves from stress app to measurer of well-being
BioBeats makes apps that apply artificial intelligence in the cloud, looking for what CEO David Plans called "instances of well-being."
BioBeats makes apps that apply artificial intelligence in the cloud, looking for what CEO David Plans called "instances of well-being."
An upcoming randomized controlled trial of BioBeats' stress assessment app will have around 700 corporate users and the trial will follow a cluster randomised controlled trial design, according to co-founder Dr David Plans.
White Cloud Capital led the fundraise, and AXA Strategic Ventures and IQ Capital, also took part in the round.